- Home
- CLPR vs SER Comparison
CLPR vs SER Comparison
Compare CLPR & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPR
- SER
- Stock Information
- Founded
- CLPR 2015
- SER 2017
- Country
- CLPR United States
- SER United States
- Employees
- CLPR N/A
- SER N/A
- Industry
- CLPR Real Estate Investment Trusts
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- CLPR Real Estate
- SER Health Care
- Exchange
- CLPR Nasdaq
- SER Nasdaq
- Market Cap
- CLPR 57.8M
- SER 56.5M
- IPO Year
- CLPR 2017
- SER 2018
- Fundamental
- Price
- CLPR $3.80
- SER $6.00
- Analyst Decision
- CLPR
- SER Strong Buy
- Analyst Count
- CLPR 0
- SER 1
- Target Price
- CLPR N/A
- SER $11.00
- AVG Volume (30 Days)
- CLPR 74.4K
- SER 9.3K
- Earning Date
- CLPR 05-12-2025
- SER 05-08-2025
- Dividend Yield
- CLPR 10.00%
- SER N/A
- EPS Growth
- CLPR N/A
- SER N/A
- EPS
- CLPR N/A
- SER N/A
- Revenue
- CLPR $152,413,000.00
- SER $51,000.00
- Revenue This Year
- CLPR N/A
- SER N/A
- Revenue Next Year
- CLPR N/A
- SER N/A
- P/E Ratio
- CLPR N/A
- SER N/A
- Revenue Growth
- CLPR 8.63
- SER N/A
- 52 Week Low
- CLPR $3.38
- SER $3.81
- 52 Week High
- CLPR $7.12
- SER $14.57
- Technical
- Relative Strength Index (RSI)
- CLPR 44.02
- SER 57.10
- Support Level
- CLPR $3.84
- SER $5.01
- Resistance Level
- CLPR $4.00
- SER $6.00
- Average True Range (ATR)
- CLPR 0.13
- SER 0.34
- MACD
- CLPR -0.03
- SER 0.00
- Stochastic Oscillator
- CLPR 0.00
- SER 90.83
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.